Choksi Laboratories (CHOKSILA) | Stock Overview & Key Data
Choksi Laboratories Performance Comparison
Stock Range
Today's Range
Low: ₹172.00
High: ₹185.00
on October 7, 2025
52 Week Range
Low: ₹60.21
High: ₹236.70
on December 31, 2024
on August 20, 2025
All-Time High: ₹236.70 on August 20, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR1.3B
EPS
2.14
P/E Ratio (TTM)
84.11
Forward P/E
N/A
P/B Ratio
5.32
PEG Ratio
-10.09
Div. Yield
N/A
ROE
6.45%
Beta
0.078
Debt to Equity
123.52
Financial Highlights
Profitability
Gross Margin
82.45%
Operating Margin
10.90%
Profit Margin
3.52%
Returns and Earnings
Return on Assets (TTM)
2.33%
Return on Equity (TTM)
6.45%
EBITDA
INR115.8M
Net Income (TTM)
INR14.9M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR60.71
Quarterly Revenue Growth (YoY)
4.70%
Quarterly Earnings Growth (YoY)
-8.50%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Choksi Laboratories CHOKSILA | 1.26B Small-cap | -8.02% | -20.17% | -3.34% | 56.24% | 95.99% | 156.84% | 352.69% | 1,519.72% |
| Dr. Lal PathLabs LALPATHLAB | 270.56B Large-cap | 1.49% | -0.48% | 11.38% | 29.09% | 4.15% | -9.31% | 33.74% | 53.87% |
| Syngene SYNGENE | 254.88B Large-cap | 3.29% | -2.31% | -0.12% | -8.98% | -27.84% | -27.89% | 15.20% | 14.34% |
| Vimta Labs VIMTALABS | 34.69B Small-cap | 6.62% | -11.13% | 60.60% | 71.29% | 49.85% | 165.46% | 322.57% | 959.87% |
| Krsnaa Diagnostics KRSNAA | 25.27B Small-cap | 1.05% | -6.11% | 5.04% | 6.53% | -14.59% | -7.92% | 61.54% | -16.08% |
| Suraksha Diagnostic SURAKSHA | 15.72B Small-cap | 1.11% | -0.76% | -6.58% | 12.85% | -20.61% | -27.68% | -27.68% | -27.68% |
Ownership & Short Interest
Insider Ownership
59.47%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
8K
Average 90-Day Volume
7K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is CHOKSILA's 52-week high and low?
- In the last 52 weeks, Choksi Laboratories reached a high of ₹236.70 (on August 20, 2025) and a low of ₹60.21 (on December 31, 2024).
- What is the market cap and P/E ratio for CHOKSILA?
- Curious about Choksi Laboratories's size and valuation? Its market capitalization stands at 1.26B. When it comes to valuation, the P/E ratio (trailing twelve months) is 84.11, and the forward P/E (looking ahead) is N/A.
- Does CHOKSILA pay dividends? If so, what's the yield?
- As for dividends, Choksi Laboratories isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Choksi Laboratories's main competitors or similar companies to consider before investing?
When looking at Choksi Laboratories, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Dr. Lal PathLabs
LALPATHLAB270.56B Healthcare Diagnostics & Research -9.31% 33.74% Syngene
SYNGENE254.88B Healthcare Diagnostics & Research -27.89% 15.20% Vimta Labs
VIMTALABS34.69B Healthcare Diagnostics & Research 165.46% 322.57% Krsnaa Diagnostics
KRSNAA25.27B Healthcare Diagnostics & Research -7.92% 61.54% Suraksha Diagnostic
SURAKSHA15.72B Healthcare Diagnostics & Research -27.68% -27.68% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Choksi Laboratories Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Choksi Laboratories's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 6.45%, the Debt to Equity ratio from the most recent quarter is 123.52, and its Gross Profit Margin stands at 82.45%.
- What is the recent revenue and earnings growth for CHOKSILA?
- Looking at Choksi Laboratories's growth, its revenue over the trailing twelve months (TTM) was INR423M. Compared to the same quarter last year (YoY), quarterly revenue grew by 4.70%, and quarterly earnings saw a YoY growth of -8.50%.
- How much of CHOKSILA stock is held by insiders and institutions?
- Wondering who owns Choksi Laboratories stock? Company insiders (like executives and directors) hold about 59.47% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.